NCT04393337

Brief Summary

Endotracheal intubation is a life-saving intervention that few infants need after birth. Although an endotracheal tube is the most reliable way of providing positive-pressure breath, the critical factor that determines the maximal efficacy of positive-pressure ventilation is the optimal placement of the endotracheal tube tip. There are various methods available to determine the initial depth of endotracheal tube (ETT) that are based on the infant's birth weight, gestational age, anthropometric measurements, and others include vocal cord guide and suprasternal palpation methods. The Neonatal Resuscitation Program (NRP) textbook, in its 7th edition of the textbook, recommends a gestational age chart and nasal-tragus length method for estimating endotracheal tube insertion depth during cardiopulmonary resuscitation of the neonate. The evidence to support these two methods is, however, limited. Hence, we designed this study to determine the accuracy of two methods, gestational age chart and nasal-tragus length method, recommended by the Neonatal Resuscitation Program.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
454

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 19, 2020

Completed
27 days until next milestone

Study Start

First participant enrolled

June 15, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

October 25, 2021

Status Verified

October 1, 2021

Enrollment Period

3 years

First QC Date

May 11, 2020

Last Update Submit

October 17, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of infants with optimally positioned endotracheal tube tip on the chest X-ray

    Endotracheal tube tip is considered optimally positioned if the tip lies between upper border of first thoracic vertebra (T1) and the lower border of second thoracic vertebra (T2) on the chest X-ray. While obtaining the antero-posterior view chest X-ray in supine position, the infant's head, neck and chest is placed in the midline with no tension on the endotracheal tube and neck being in neutral position (i.e. neck neither flexed nor extended). Just before obtaining the film, the investigator/research assistant should re-confirm that the endotracheal tube is secured in a standardize manner at the estimated depth based on the treatment arm assigned.

    within 4 hours of endotracheal intubation

Secondary Outcomes (8)

  • Proportion of infants with endotracheal tube tip above T1 vertebra

    within 4 hours of endotracheal intubation

  • Proportion of infants with endotracheal tube tip below T2 vertebra

    within 4 hours of endotracheal intubation

  • Proportion of infants with pneumothorax

    36 weeks of post-menstrual age

  • Proportion of infants with requiring endotracheal tube repositioning (advance or withdrawn) following chest X-ray

    24 hours

  • Proportion of infants with oxygen therapy

    28 days from the birth

  • +3 more secondary outcomes

Study Arms (2)

Gestational Age Chart Method

EXPERIMENTAL

In this method, the endotracheal tube insertion depth is obtained from the gestational age chart provided in the 7th edition textbook of neonatal resuscitation program (adapted from Kempley et al. PubMed identifier number: 18372092)

Other: Gestational Age Chart Method

Nasal-Tragus Length Method

ACTIVE COMPARATOR

In this method, the endotracheal tube insertion depth is calculated based on the formula-the distance from nasal septum tip to ear tragus+1 cm

Other: Nasal-Tragus Length Method

Interventions

The endotracheal tube insertion depth is obtained by the gestational age chart

Gestational Age Chart Method

The endotracheal tube insertion depth is obtained by the nasal-tragus method formula

Nasal-Tragus Length Method

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants (less than 28 days of life) between 23 weeks 0 days and 41 weeks 6 days gestational age
  • Infants requiring oral intubation in the delivery room or in neonatal intensive care unit

You may not qualify if:

  • Infants with major chromosomal anomalies, including trisomy 13, trisomy 18, and trisomy 21
  • Infants with major anomalies, including craniofacial anomalies and facial dysmorphism that may affect the nasal-tragus length

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

King Fahad Hospital, AlBaha University

Al Bahah, Saudi Arabia

RECRUITING

King Abdullah bin Abdulaziz University Hospital

Riyadh, 13412, Saudi Arabia

RECRUITING

King Faisal Specialist Hospital & Research Centre

Riyadh, Saudi Arabia

RECRUITING

Related Publications (1)

  • Razak A, Faden M, Alghamdi J, Binmanee A, Alonazi AH, Hamdoun A, Almugaiteeb S, Patel W, Katar H, Lora F, Alismail A, Lavery A, Hamama I, Alsaleem N, Alshaikh M, Alrasheed L, Aldibasi O. Randomised trial estimating length of endotracheal tube insertion using gestational age or nasal-tragus length in newborns: a study protocol. BMJ Open. 2022 Jan 19;12(1):e055628. doi: 10.1136/bmjopen-2021-055628.

MeSH Terms

Conditions

Bronchopulmonary DysplasiaPneumothoraxDeath

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPleural DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding of the clinicians, nurses, and patient caregivers are impractical. However, to minimize the bias, we will neither mention the method used to estimate the endotracheal tube insertion depth to the patient caregivers explicitly and nor record in the patient charts. We will blind the primary outcome assessment by masking the consultant pediatric radiologist to the group assignment. Similarly, the consultant pediatric radiologist will determine the following secondary outcomes-endotracheal tube tip above the upper border of T1 vertebra, endotracheal tube tip below the lower border of T2 vertebra, and pneumothorax. The other secondary outcomes (endotracheal tube repositioning after the X-ray, oxygen therapy at 28 days, oxygen therapy, or positive pressure support at 36 weeks post-menstrual age, duration of invasive ventilation, and death before discharge) will be determined by the trained research assistant.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Eligible infants will be randomly assigned (1:1) to the 'gestational age chart' or 'nasal-tragus length' method We will stratify the randomization by gestational age at birth (\<28 weeks and \>28 weeks) and participating center. An independent researcher will generate the randomization sequence with a computer at the website www.sealedenvelope.com hosted by King Abdullah bin Abdulaziz University Hospital, Saudi Arabia. The researcher will upload the sequence to the in-built randomization module within the Research Electronic Data Capture (REDCap) system. The sequence is inaccessible to the trial investigators. We will conceal the allocation by incorporating the random permuted blocks of size 2 and 4 sequences within the REDCap system.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

May 11, 2020

First Posted

May 19, 2020

Study Start

June 15, 2020

Primary Completion

June 1, 2023

Study Completion

December 1, 2023

Last Updated

October 25, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations